DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3Dr. Reddy's Laboratories
02 1Polfa Tarchomin
03 1NanoAlvand
04 1Supriya Lifescience
05 14Accord Healthcare Pty. Ltd.
06 2Accord healthcare
07 1Actavis Inc
08 1Amneal Pharmaceuticals
09 1Aurobindo Pharma Limited
10 2Bristol Laboratories Ltd
11 7Bristol Myers Squibb
12 2Celgene Corporation
13 1CinnaGen
14 1Cipla
15 1DR REDDY'S LABORATORIES LTD
16 14Dr Reddy's Laboratories (Australia) Pty Ltd
17 1Dr Reddy's Laboratories (Pty) Ltd
18 14EUGIA PHARMA (AUSTRALIA) PTY LTD
19 1Fresenius Kabi Austria
20 1GetWell Pharmaceutical
21 1Hainan Poly Pharm
22 1Hansoh Pharma
23 1Hetero Drugs
24 2Hikma Pharmaceuticals
25 1JAMP PHARMA
26 1Jodas Expoim Pvt. Ltd
27 28Juno Pharmaceuticals Pty Ltd
28 1Key Oncologics
29 1Lupin Ltd
30 1MSN Laboratories
31 1Meitheal Pharmaceuticals
32 1Natco Pharma
33 1Norvium
34 1ORIFARM GROUP AS
35 1Panacea Biotec Limited
36 1Reliance Life Sciences Private Limited
37 1SEACROSS PHARMACEUTICALS
38 1Sakar Healthcare
39 2Samyang Biopharmaceuticals
40 15Sandoz B2B
41 1Shilpa Medicare
42 14Southern XP Pty Ltd
43 1Sun Pharmaceutical Industries Limited
44 1Teva Pharmaceutical Industries
45 2TherDose Pharma
46 1Vama Lifecare
01 1Azacitidina 25Mg/Ml 100Mg 1 Unit Parenteral Use
02 1FREEZE-DRIED POWDER
03 2INJ
04 1IV
05 1Injectable
06 10Injection
07 1Lyo.Inj
08 2Lyophilized Injection
09 6POWDER FOR SUSPENSION
10 17POWDER;INTRAVENOUS, SUBCUTANEOUS
11 1Powder for Solution for Injection
12 1Powder for infusion, solution
13 2Powder for injection fluid, suspension
14 3TABLET
15 2TABLET;ORAL
16 1Vial
17 98injection
18 3Blank
01 2DISCN
02 1Dossier Available
03 4Generic
04 1Lead Market Dossiers- Approved in both US & EU
05 1Lead Market Dossiers- Filed
06 1Originator
07 17RX
08 126Blank
01 1AZACITE
02 17AZACITIDINE
03 14AZACITIDINE EUGIA
04 5AZACITIDINE FOR INJECTION
05 2AZALID
06 14Azacitidine Accord
07 1Azacitidine DRL
08 14Azacitidine Dr.Reddy's
09 14Azacitidine Juno
10 14Azacitidine MSN
11 1Azacitidine SUN
12 14Azacitidine SXP
13 14Azacitidine Sandoz
14 1CAPETED
15 1Intaza
16 2Leukaza
17 4ONUREG
18 3Onureg
19 2VIDAZA
20 4Vidaza
21 11Blank
01 101Australia
02 8Canada
03 1China
04 10India
05 2Iran
06 1Italy
07 3Norway
08 1Poland
09 3South Africa
10 2South Korea
11 20USA
12 1United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2013-09-16
Application Number : 201537
Regulatory Info : RX
Registration Country : USA
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Available
Registration Country : Poland
Brand Name :
Dosage Form : Powder for Solution for Injection
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Available
Registration Country : Poland
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Leukaza
Dosage Form : Vial
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in both US & EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in both US & EU
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2018-07-02
Application Number : 207475
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2016-04-29
Application Number : 208216
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2022-02-03
Application Number : 211549
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ONUREG
Dosage Form : TABLET;ORAL
Dosage Strength : 200MG
Packaging :
Approval Date : 2020-09-01
Application Number : 214120
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ONUREG
Dosage Form : TABLET;ORAL
Dosage Strength : 300MG
Packaging :
Approval Date : 2020-09-01
Application Number : 214120
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VIDAZA
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2004-05-19
Application Number : 50794
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2018-05-04
Application Number : 209540
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2020-06-08
Application Number : 209337
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2019-02-27
Application Number : 210748
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2020-11-02
Application Number : 212128
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2024-05-16
Application Number : 212580
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2017-06-23
Application Number : 207234
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2016-04-28
Application Number : 204949
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2016-09-29
Application Number : 207518
Regulatory Info : RX
Registration Country : USA
